Sanbactacef-XP 1.125 Injection
By Sanbactacef-XP
Rx
1 Injection in a Vial

Composition
Ceftriaxone(1000mg) + Tazobactum(125mg)

Manufacturer - Santo Formulations
Solan, Himachal Pradesh, India

Expires on or after
March, 2026

liver
When using Sanbactacef-XP 1.125 Injection, it's important to be cautious if you have severe liver disease. In such cases, the dosage of Sanbactacef-XP 1.125 Injection may need to be adjusted. It's crucial to consult your doctor before starting treatment with Sanbactacef-XP 1.125 Injection if you have severe liver disease. However, if you have mild to moderate liver disease, dose adjustment of Sanbactacef-XP 1.125 Injection is not typically recommended. Always follow your doctor's guidance and advice regarding the use of Sanbactacef-XP 1.125 Injection in relation to your liver health.

kidney
Limited data exists on the use of Sanbactacef-XP 1.125 Injection in people with kidney issues. It's recommended to seek advice from your doctor.

alcohol
When taking Sanbactacef-XP 1.125 Injection, it is safe to consume alcohol as it does not lead to any harmful effects.

driving
Sanbactacef-XP 1.125 Injection may reduce alertness and cause drowsiness or dizziness. It is advised not to drive if experiencing these symptoms.

pregnancy
Sanbactacef-XP 1.125 Injection is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
Sanbactacef-XP 1.125 Injection should be used cautiously while breastfeeding. It is advised to temporarily stop breastfeeding until the mother's treatment is finished and the medicine is cleared from her system.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | - |
₹135.9
₹151
10% OFF
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024
